The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)-3-(3-(trifluoromethoxy)phenyl)urea ID: ALA4861929
PubChem CID: 164619937
Max Phase: Preclinical
Molecular Formula: C20H15F3N6O2
Molecular Weight: 428.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1ccc(-c2cnc3ccc(NC(=O)Nc4cccc(OC(F)(F)F)c4)cc3n2)n1
Standard InChI: InChI=1S/C20H15F3N6O2/c1-29-8-7-16(28-29)18-11-24-15-6-5-13(10-17(15)27-18)26-19(30)25-12-3-2-4-14(9-12)31-20(21,22)23/h2-11H,1H3,(H2,25,26,30)
Standard InChI Key: NVXZWJRHVGIGTA-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 34 0 0 0 0 0 0 0 0999 V2000
40.3767 -13.9996 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
39.9722 -13.2938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5632 -13.9970 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
31.4563 -13.3515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4552 -14.1793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1673 -14.5883 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.1656 -12.9427 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.8783 -13.3479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8791 -14.1752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5917 -14.5823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3041 -14.1673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2994 -13.3411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5861 -12.9377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0087 -12.9282 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7230 -13.3325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4324 -12.9196 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7280 -14.1538 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.1425 -13.3238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1432 -14.1451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8566 -14.5534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5669 -14.1363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5593 -13.3108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8453 -12.9103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7496 -12.9389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6649 -12.1262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8658 -11.9554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4564 -12.6628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0027 -13.2705 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6436 -12.7474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2626 -12.8946 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.6779 -12.8793 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
12 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 1 0
28 24 2 0
4 24 1 0
27 29 1 0
22 30 1 0
30 2 1 0
2 31 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 428.37Molecular Weight (Monoisotopic): 428.1209AlogP: 4.57#Rotatable Bonds: 4Polar Surface Area: 93.96Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.28CX Basic pKa: 1.24CX LogP: 4.72CX LogD: 4.72Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.50Np Likeness Score: -1.96
References 1. Sagar S, Singh S, Mallareddy JR, Sonawane YA, Napoleon JV, Rana S, Contreras JI, Rajesh C, Ezell EL, Kizhake S, Garrison JC, Radhakrishnan P, Natarajan A.. (2021) Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy., 222 [PMID:34098465 ] [10.1016/j.ejmech.2021.113579 ]